Location History:
- Geneva, CH (2012)
- Annemasse, FR (2014)
Company Filing History:
Years Active: 2012-2014
Title: Inventor Profile: Yves Thollon
Introduction
Yves Thollon is an esteemed inventor based in Annemasse, France. With a focus on developing innovative compounds, he has made significant contributions to the field of pharmacology. Thollon holds two patents, demonstrating his commitment to advancing science and healthcare.
Latest Patents
Yves Thollon's latest patents revolve around alkynyl derivatives as modulators of metabotropic glutamate receptors, specifically subtype 5 (mGluR5). These novel compounds are designed for the treatment of central nervous system disorders as well as other conditions modulated by mGluR5 receptors. His work provides promising avenues for therapeutic interventions in complex neurobiological conditions.
Career Highlights
Thollon's career has been marked by his association with Addex Pharma, S.A., where he has been able to leverage his innovative approach to drug development. His extensive research and patent filings showcase his dedication to exploring new methodologies in medicinal chemistry.
Collaborations
Throughout his career, Yves has had the privilege of collaborating with talented individuals such as Anne-Sophie Bessis and Christelle Bolea. These partnerships have fostered a dynamic environment that encourages creativity and scientific exploration.
Conclusion
In summary, Yves Thollon exemplifies the spirit of innovation and dedication to improving healthcare through his inventions. His patents serve as a testament to his contributions to science, and his ongoing work continues to enhance our understanding of therapeutic possibilities for various disorders.